Ultrasound Use Investigated to Treat Cancer
|
By MedImaging International staff writers Posted on 15 Sep 2009 |
According to a Canadian researcher, studying the complex relationship between cells and sound could translate into big advances in cancer treatment, including more effective treatment monitoring, less invasive procedures, and healthcare savings.
Dr. Michael Kolios, an associate professor in Ryerson University's (Toronto, Canada) department of physics is examining how dying cancer cells scatter sound in ultrasound procedures. "It's like a rock falling into a pond,” explained Dr. Kolios. "Bigger rocks create bigger splashes and scatter ripples. In contrast, when cancer cells die and break into smaller pieces, that is when their ‘splash' scatters sound.” In particular, Dr. Kolios is analyzing the frequency emitted by cancer cells. The smaller the cells, the higher the frequency. Ultrasound operates in the same general way as radar sounds waves are sent out and when they hit something, they bounce back. In this instance, instead of detecting airplanes or ships, ultrasound is used to pinpoint and evaluate disease in the human body.
With the use of high-frequency ultrasound, physicians could determine a tumor's response to therapy early on in treatment. As a result, better-informed decisions could be made as to whether to continue with the prescribed treatment plan or develop a different one. That is the principle behind Dr. Kolios' newest research project. The research is part of Dr. Kolios' larger studies on ultrasound as a noninvasive way to investigate cell death, a collaboration with Dr. Gregory Czarnota, an adjunct physics professor at Ryerson and a researcher at Sunnybrook Health Sciences Centre (Toronto, Canada), and assistant Ryerson physics professor Dr. Carl Kumaradas.
Dr. Kolios' work could have significant impact on the way cancer treatments are monitored. Currently, patients must undergo a full course of radiation or chemotherapy before doctors assess whether or not the treatment has achieved its intended effect. Depending on the type of therapy, the cost of care can start at US$60,000.
High-frequency ultrasound could also help patients improve their quality of life by avoiding the unpleasant side effects of traditional treatment, while potentially save the healthcare system tens of thousands of dollars per treatment. That money, in turn, could be put toward the cost of another, more effective therapy. Research on the use and outcomes of high-frequency ultrasound is timely. "As the population ages, more people are getting cancer,” noted Dr. Kolios.
While Dr. Kolios is studying high-ultrasound frequencies (10-60 MHz), his research assistant Eric Strohm, a master's student in biomedical physics, is exploring ultra-high frequencies of more than 100 MHz. Frequencies in this range make up the field of acoustic microscopy and facilitate high-resolution viewing of single cells.
Related Links:
Ryerson University
Dr. Michael Kolios, an associate professor in Ryerson University's (Toronto, Canada) department of physics is examining how dying cancer cells scatter sound in ultrasound procedures. "It's like a rock falling into a pond,” explained Dr. Kolios. "Bigger rocks create bigger splashes and scatter ripples. In contrast, when cancer cells die and break into smaller pieces, that is when their ‘splash' scatters sound.” In particular, Dr. Kolios is analyzing the frequency emitted by cancer cells. The smaller the cells, the higher the frequency. Ultrasound operates in the same general way as radar sounds waves are sent out and when they hit something, they bounce back. In this instance, instead of detecting airplanes or ships, ultrasound is used to pinpoint and evaluate disease in the human body.
With the use of high-frequency ultrasound, physicians could determine a tumor's response to therapy early on in treatment. As a result, better-informed decisions could be made as to whether to continue with the prescribed treatment plan or develop a different one. That is the principle behind Dr. Kolios' newest research project. The research is part of Dr. Kolios' larger studies on ultrasound as a noninvasive way to investigate cell death, a collaboration with Dr. Gregory Czarnota, an adjunct physics professor at Ryerson and a researcher at Sunnybrook Health Sciences Centre (Toronto, Canada), and assistant Ryerson physics professor Dr. Carl Kumaradas.
Dr. Kolios' work could have significant impact on the way cancer treatments are monitored. Currently, patients must undergo a full course of radiation or chemotherapy before doctors assess whether or not the treatment has achieved its intended effect. Depending on the type of therapy, the cost of care can start at US$60,000.
High-frequency ultrasound could also help patients improve their quality of life by avoiding the unpleasant side effects of traditional treatment, while potentially save the healthcare system tens of thousands of dollars per treatment. That money, in turn, could be put toward the cost of another, more effective therapy. Research on the use and outcomes of high-frequency ultrasound is timely. "As the population ages, more people are getting cancer,” noted Dr. Kolios.
While Dr. Kolios is studying high-ultrasound frequencies (10-60 MHz), his research assistant Eric Strohm, a master's student in biomedical physics, is exploring ultra-high frequencies of more than 100 MHz. Frequencies in this range make up the field of acoustic microscopy and facilitate high-resolution viewing of single cells.
Related Links:
Ryerson University
Latest Ultrasound News
- AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
- Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Channels
Radiography
view channel
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more
AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreGeneral/Advanced Imaging
view channelNew SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more
Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
Obesity surgery improves weight and comorbidity profiles, yet clinicians lack tools to monitor organ-level metabolic recovery after the procedure. A clear view of systemic changes could refine follow-up... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







